This site uses cookies to bring you the best experience. Find out more
Skip to main content
↑

News

Find Out The Latest

Keep in touch with exciting developments from The Oxford Science Park and its occupiers here.

Contact us on comms@oxfordsp.com if you would like to know more about any of these stories.

You can also follow us on LinkedIn  

Exscientia and Recursion Enter Definitive Agreement

Exscientia and Recursion Enter Definitive Agreement

13 Aug 2024

Recursion and Exscientia plc have announced the companies have entered into a definitive agreement, combining Recursion, a leading clinical stage technology-enabled biotech company decoding biology to industrialize drug discovery, with Exscientia, a technology-driven clinical stage drug design and development company, committed to creating more effective medicines for patients, faster. Chris Gibson, Co-Founder and CEO of Recursion as well as... Read more

Ellison Institute expands to new building on The Oxford Science Park to accommodate growth

Ellison Institute expands to new building on The Oxford Science Park to accommodate growth

01 Aug 2024

The Ellison Institute of Technology Oxford (EIT) is expanding into Winchester House on The Oxford Science Park to accommodate for significant growth and an anticipated tripling in headcount over the coming years. The phased move, starting this month, will see the interdisciplinary research and development facility EIT taking full occupancy of Winchester House throughout the remainder of the year. Winchester House was built in 2008... Read more

Mace awarded contract to deliver The Daubeny Project at The Oxford Science Park

Mace awarded contract to deliver The Daubeny Project at The Oxford Science Park

22 Jul 2024

Mace has been awarded a £184 million contract to deliver the next expansion phase at The Oxford Science Park, The Daubeny Project. This landmark project will see the construction of three new state-of-the-art laboratory and office buildings, further cementing Oxford's position as a world-leading centre for scientific innovation. The expansion will add 400,500 sq ft of premium laboratory and office space to the park, addressing the critical... Read more

Moa harvests global deal for new herbicide

Moa harvests global deal for new herbicide

11 Jul 2024

Oxford, UK  8 July2024 – Agricultural biotech firm Moa Technology has signed a research and commercial partnership with Nufarm,a global agricultural innovator based in Melbourne, Australia. Moa has discovered several promising new classes of herbicide with its breakthrough innovation platform, which are currently in field trials in the US, UK, France and Spain. The deal provides Nufarm exclusive access to a new mode of action product in one... Read more

Ochre Bio enters into multi-year data licence agreement with GSK to further investigate the drivers of liver disease

Ochre Bio enters into multi-year data licence agreement with GSK to further investigate the drivers of liver disease

14 Jun 2024

We are delighted to announce that a Park occupier Ochre Bio has entered a multi-year data licence agreement with GSK to investigate the drivers of liver disease, a condition which can be fatal, killing 1 in 25 people worldwide. The partnership aims to prioritise and speed up the development of new treatments for liver conditions. Ochre Bio enters into a multi-year data licence agreement with GSK to further investigate the drivers of liver... Read more

The Daubeny Project

Imaginative design, inspiring spaces.

450,000 sq ft of
premium lab space
completing 2026

Discover More